Paul Tudor Jones II started to build up the position in Prometheus Biosciences in Q3 2022 and continued to invest until Q1 2023. Since then they sold 23 Thousand shares. The investor sold all their shares in Q2 2023 and doesn't own any shares in Prometheus Biosciences anymore.